✨ Slovenská sporiteľňa (ERSTE Group) joined Crowdberry as a shareholder

DNA ERA

Personalised services to reveal health risks, predispositions and athletic potential through direct genetic DNA analysis

SK
CompaniesEquityFunded

DNA ERA

Knowledge about DNA plays an important role in disease prevention, personalised medicine and improving one’s quality of life. The DNA biotechnology company DNA ERA makes it possible to put your health in your own hands. Through direct genetic analysis, DNA ERA tests can reveal predispositions to disease, highlight genetic risks and identify your athletic potential. Anyone can provide saliva samples from the comfort of their own home and, once processed, will receive the information in the form of a clear and comprehensive digital report that is constantly updated according to the latest validated scientific studies. DNA ERA uses its own software and algorithms to process the results of the laboratory analysis from a certified laboratory and produce the in-depth report, which, in addition to the results of the analysis, also contains recommendations for prevention and creating the optimum lifestyle.

DNA ERA currently has three types of tests: the Lifestyle Test, Health Test and Complex Test. They target different parts of the genetic code and the exact needs of a group of customers – from family planners to healthy lifestyle enthusiasts to athletes. Within B2B, DNA ERA offers DNA testing options to companies as a benefit for employees or other partners.

Founded by a geneticist and a mathematician, the Šiška husband and wife team, the company cooperates with several expert partners, including scientist Pavol Čekan and geneticist and vice-dean of Charles University in Bratislava Dr Miroslava Slaninová. DNA ERA entered the Czech market in 2021, with plans for an English version of the tests, expansion abroad and a further scaling of the company’s business model.

The company’s goal is to bring DNA analysis to anyone who wants to take charge of their own health. Along with the growth investment, DNA ERA will bring additional new health analysis services to the market with the ability to repeatedly track the impact of recommended changes (the result of the analysis) on your health. This represents a step towards customized medicine and personalized health services for your identified predispositions and health risks. Be part of this vision and become a co-owner of DNA ERA, a Slovak biotech company of the future.

About Investment Opportunity

To view this section, please register.

Product

To view this section, please register.

To view this section, please register.

To view this section, please register.

To view this section, please register.

Team

To view this section, please register.

To view this section, please register.

The market and competition

To view this section, please register.

Risks

To view this section, please register.

Investment purpose

To view this section, please register.

To view this section, please register.

To view this section, please register.

Media

To view this section, please register.

To view this section, please register.

€1,000,000
Target amount
85
Investors
25 - 50% p.a.
Required return

You cannot invest in this opportunity at the moment